STRATEGIC CAPITAL ACQUISITION
Embedded Files
THE FUNDING ARCHITECTURE
I specialize in architecting the frameworks required to secure and orchestrate non-dilutive capital for industrial R&D and institutional growth. By aligning organizational innovation roadmaps with national and international funding priorities, I have facilitated a pipeline of strategic capital acquisition, ensuring 100% compliance and rigorous project governance across the full funding lifecycle.
GLOBAL & NATIONAL FUNDING PORTFOLIOS
NATIONAL STRATEGIC AGENCIESÂ (Govt. of India)
Technology & Electronics: DST, MeitY, TDB, CSIR.
Biotech & Healthcare: DBT, BIRAC, ICMR.
Infrastructure & Academia: MHRD/MoE, UGC, ICAR.
INTERNATIONAL INDUSTRIAL R&D PROGRAMS
Bilateral Funds: Indo-Israel (I4F), Indo-Singapore, Indo-Spain, and Indo-UK Collaborative Industrial R&D Programmes.
Global Partners: Israel Innovation Authority, Enterprise Singapore, Innovate UK.
CORE CAPABILITIES: CAPITAL ORCHESTRATIONÂ
Strategic Pipeline Development: Systematic identification and thematic alignment of big funding opportunities with corporate innovation roadmaps (AI, Biotech, Advanced Materials).
Full Lifecycle Governance: End-to-end oversight from high-stakes proposal architecture to post-award financial compliance, audit-readiness, and milestone reporting.
Ecosystem Stakeholder Diplomacy: Negotiating complex, multi-country collaboration agreements and IPR frameworks between industry, ministries, and international partners.
Risk Mitigation & Financial Stewardship: Applying rigorous cost-benefit analysis and risk-assessment principles to ensure 100% business continuity and grant-to-market success.
Page updated
Google Sites
Report abuse